Trials / Active Not Recruiting
Active Not RecruitingNCT05891483
Efficacy and Safety of SHR-1905 Injection in Patients With Chronic Rhinosinusitis With Nasal Polyps
A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Phase 2 Efficacy and Safety Study of SHR-1905 in Patiens With Chronic Rhinosinusitis With Nasal Polyps
- Status
- Active Not Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 114 (actual)
- Sponsor
- Guangdong Hengrui Pharmaceutical Co., Ltd · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The study is being conducted to evaluate the efficacy, and safety of SHR-1905 injection in subjects with chronic rhinosinusitis with nasal polyps (CRSwNP), as well as to explore the reasonable dosage of SHR-1905 injection for CRSwNP.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SHR-1905 Injection | SHR-1905 Injection |
| DRUG | SHR-1905 Placebo Injection | SHR-1905 Placebo Injection |
Timeline
- Start date
- 2023-09-04
- Primary completion
- 2026-02-01
- Completion
- 2026-02-01
- First posted
- 2023-06-07
- Last updated
- 2024-06-21
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05891483. Inclusion in this directory is not an endorsement.